Prescription drug · NDA AUTHORIZED GENERIC
Clonidine NDC 52817-375
Clonidine .17 mg/1 · Tablet, Extended release · Oral · TruPharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 52817-375-30 | 52817037530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52817-375-30)Marketed from Jan 11, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clonidine
- Generic name (nonproprietary)
- clonidine
- Active ingredients
- Clonidine — .17 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- TruPharma, LLC
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 022500
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha2-Agonists (Mechanism)
- Identifiers
- Product ID 52817-375_0eb6d1fe-949a-312a-e063-6294a90ae10cSPL ID 0eb6d1fe-949a-312a-e063-6294a90ae10cSPL set ID 2311836b-de63-4e8c-a021-600c40110024RxCUI 885880UNII MN3L5RMN02UPC 0352817375308
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N452817037530followed by a unit qualifier and the quantityPackage 52817-0375-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Clonidine extended-release tablets are indicated in the treatment of hypertension. Clonidine extended-release tablets may be employed alone or concomitantly with other antihypertensive agents. Clonidine extended-release tablets are a central alpha-adrenergic agonist indicated for: Treatment of hypertension ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 022500
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Nexiclon XRclonidine | Clonidine .17 mg/1 | Tablet, Extended releaseOral | Rosemont Pharmaceuticals LLC | 71511-503 |
| Clonidine | Clonidine .17 mg/1 | Tablet, Extended releaseOral | PALMETTO PHARMACEUTICALS INC. | 68134-603 |